Uveitis in Behcet disease: an analysis of 880 patients, Am J Ophthalmol, vol.138, issue.3, pp.373-380, 2004. ,
Behcet's disease in Iran: analysis of 6500 cases, Int J Rheum Dis, vol.13, issue.4, pp.367-373, 2010. ,
,
, J Fr Ophtalmol, vol.20, issue.8, pp.592-598, 1997.
Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease, Ann Rheum Dis, vol.68, issue.10, pp.1528-1534, 2009. ,
The use of interferon alpha in Behcet disease: review of the literature, Semin Arthritis Rheum, vol.33, issue.5, pp.320-335, 2004. ,
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop, Am J Ophthalmol, vol.140, issue.3, pp.509-516, 2005. ,
Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behcet disease, Am J Ophthalmol, vol.146, issue.6, pp.837-844, 2008. ,
Results of interferon-alfa therapy in patients with Behcet uveitis, Graefes Arch Clin Exp Ophthalmol, vol.244, issue.12, pp.1692-1695, 2006. ,
Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a, J Rheumatol, vol.35, issue.5, pp.896-903, 2008. ,
Ocular involvement in Behcet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a ,
, Ophthalmologe, vol.101, issue.2, pp.129-134, 2004.
Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study, Arch Dermatol, vol.138, issue.4, pp.467-471, 2002. ,
Treatment of Adamantiades-Behcet disease with systemic interferon alfa, Arch Dermatol, vol.134, issue.8, pp.1010-1016, 1998. ,
Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behcet uveitis, Arch Ophthalmol, vol.129, issue.3, pp.288-294, 2011. ,
Behcet's disease: ocular effects and treatment, Prog Retin Eye Res, vol.27, issue.1, pp.111-136, 2008. ,
Role of nuclear factor-kappaB in the antiviral action of interferon and interferonregulated gene expression, J Biol Chem, vol.279, issue.30, pp.31304-31311, 2004. ,
Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: an open study, Isr Med Assoc J, vol.4, issue.11, pp.928-930, 2002. ,
Safety and effectiveness of interferon alpha-2a in treatment of patients with Behcet's uveitis refractory to conventional treatments, Ophthalmology, vol.117, issue.7, pp.1430-1435, 2010. ,
Long-term remission after cessation of interferon-alpha treatment in patients with severe uveitis due to Behcet's disease, Arthritis Rheum, vol.62, issue.9, pp.2796-2805, 2010. ,
Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis, Br J Ophthalmol, vol.87, issue.4, pp.423-431, 2003. ,
Anti-TNF agents for Behcet's disease: analysis of published data on 369 patients, Semin Arthritis Rheum, vol.41, issue.1, pp.61-70, 2011. ,
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study, Rheumatology (Oxford), vol.46, issue.7, pp.1161-1164, 2007. ,
Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects, Ann N Y Acad Sci, vol.1110, pp.474-484, 2007. ,
Effects of infliximab in the treatment of refractory posterior uveitis of Behcet's disease after withdrawal of infusions, Int Ophthalmol, vol.30, issue.5, pp.577-581, 2010. ,
Multicenter study of infliximab for refractory uveoretinitis in Behcet disease, Arch Ophthalmol, vol.130, issue.5, pp.592-598, 2012. ,
Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders, Ophthalmology, vol.121, issue.3, pp.785-796, 2014. ,
Complete regression of retinal neovascularization after therapy with interferon alfa in Behcet's disease, Br J Ophthalmol, vol.84, issue.12, pp.1437-1438, 2000. ,
Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behcet disease, Am J Ophthalmol, vol.146, issue.6, pp.845-850, 2008. ,
Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells, Rheumatol Int, vol.27, issue.5, pp.417-424, 2007. ,
Etiopathogenesis of Behcet's disease, Autoimmun Rev, vol.9, issue.4, pp.241-245, 2010. ,
New insights into the pathogenesis of Behcet's disease, Autoimmun Rev, vol.11, issue.10, pp.687-698, 2012. ,
, Rev Med Interne, vol.35, issue.2, pp.81-89, 2014.
Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis, Am J Ophthalmol, vol.144, issue.1, pp.55-61, 2007. ,
Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review, J Viral Hepat, vol.20, issue.9, pp.593-599, 2013. ,
Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab, Clin Exp Rheumatol, vol.22, issue.6, pp.756-758, 2004. ,
A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes, Arch Ophthalmol, vol.123, issue.7, pp.903-912, 2005. ,